Akebia Therapeutics Inc. (AKBA)
NASDAQ: AKBA
· Real-Time Price · USD
3.24
-0.05 (-1.52%)
At close: Aug 15, 2025, 3:59 PM
3.25
0.31%
After-hours: Aug 15, 2025, 07:55 PM EDT
Akebia Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 113.37M | 51.87M | 34.02M | 39.5M | 41.96M | 42.92M | 46.53M | 53.57M | 56.95M | 90.47M | 144.76M | 143.89M | 174.56M | 149.8M | 207.2M | 246.99M | 252.76M |
Short-Term Investments | n/a | n/a | n/a | 83.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20M |
Long-Term Investments | n/a | n/a | n/a | 1.67M | 1.66M | 1.65M | 1.65M | 1.72M | n/a | 2.7M | n/a | n/a | n/a | 2.04M | n/a | 1.6M | 2M |
Other Long-Term Assets | 38.34M | 37.38M | 27.13M | 16.11M | 10.13M | -25.27M | 3.86M | 3.35M | 5.24M | 5.37M | 26.27M | 34.95M | 39.42M | 49.75M | 69.6M | 67.47M | 39.64M |
Receivables | 61.54M | 34.37M | 32.17M | 29.77M | 26.62M | 39.29M | 22.59M | 19.57M | 17.78M | 41.06M | 23.09M | 81.87M | 64.58M | 50.88M | 49.69M | 35.01M | 35.23M |
Inventory | 19.73M | 16.24M | 20.49M | 23.87M | 25.53M | 15.69M | 18.44M | 20.91M | 20.6M | 21.76M | 40.04M | 36.27M | 39.42M | 38.2M | 33.69M | 37.9M | 44.81M |
Other Current Assets | 7.92M | 7.32M | 13.44M | 7.33M | 4.81M | 20.24M | 22.04M | 24.4M | 25.38M | 17.25M | n/a | n/a | n/a | 4.31M | n/a | n/a | n/a |
Total Current Assets | 203.78M | 113.83M | 100.12M | 112.1M | 112.94M | 118.15M | 109.6M | 118.45M | 120.72M | 184.95M | 237.51M | 304.16M | 302.69M | 272.01M | 330.08M | 331.08M | 365.02M |
Property-Plant & Equipment | 9.02M | 10.42M | 11.83M | 13.26M | 14.66M | 16.05M | 17.44M | 18.81M | 32.77M | 34.37M | 35.96M | 37.53M | 39.08M | 40.61M | 30.39M | 32.11M | 33.84M |
Goodwill & Intangibles | 59.04M | 59.04M | 68.06M | 77.06M | 86.08M | 95.09M | 104.1M | 113.11M | 118.13M | 127.14M | 136.15M | 145.16M | 154.17M | 163.18M | 172.19M | 181.2M | 190.21M |
Total Long-Term Assets | 106.4M | 106.84M | 107.02M | 108.1M | 112.53M | 123.55M | 125.4M | 135.26M | 156.14M | 166.88M | 198.38M | 217.64M | 232.67M | 253.54M | 272.18M | 280.79M | 263.69M |
Total Assets | 310.19M | 220.67M | 207.14M | 220.2M | 225.48M | 241.7M | 235M | 253.71M | 276.86M | 351.83M | 435.89M | 521.8M | 535.36M | 525.55M | 602.27M | 611.86M | 628.7M |
Account Payables | 12.66M | 15.18M | 13.49M | 10.11M | 11.88M | 14.63M | 9.04M | 11.78M | 12.58M | 18.02M | 19.71M | 24.94M | 19.47M | 33.59M | 28.81M | 41.98M | 30.54M |
Deferred Revenue | 1.24M | n/a | n/a | 58.03M | 14.26M | 22.94M | 43.3M | 43.3M | 43.3M | 3.74M | 1.26M | 5.05M | 10.44M | 20.91M | 15.69M | 11.87M | 18.25M |
Short-Term Debt | n/a | n/a | n/a | 2.01M | 1.99M | 19.55M | 8M | 24M | 24M | 32M | 65.95M | 98.16M | 97.85M | 97.54M | n/a | n/a | n/a |
Other Current Liabilities | 47.39M | 51.14M | 46.93M | 62.77M | 41.03M | 18.26M | -9.26M | -13.87M | -21.08M | 52.53M | 38.9M | 40.42M | 42.74M | 83.79M | 44.23M | 39.08M | 39.23M |
Total Current Liabilities | 91.23M | 80.91M | 65.71M | 107.3M | 66.49M | 99.87M | 79.7M | 92.18M | 82.94M | 124.76M | 187.97M | 233.68M | 253.91M | 256.49M | 189.21M | 165.59M | 172.68M |
Long-Term Debt | 46.51M | 38.69M | 38.35M | 91.13M | 83.64M | 71.2M | 90.67M | 75.03M | 26.3M | 91.56M | n/a | n/a | n/a | n/a | 97.23M | 96.92M | 96.61M |
Other Long-Term Liabilities | 145.74M | 146.7M | 148.54M | 49.22M | 51.67M | 48.98M | 50.52M | 58.52M | 111.26M | 57.47M | 160.1M | 150.79M | 157.39M | 137.42M | 130.46M | 136.39M | 103.04M |
Total Long-Term Liabilities | 194.38M | 188.94M | 191.84M | 146.65M | 186.25M | 172.42M | 194.72M | 188.34M | 208.27M | 217.73M | 234.08M | 225.82M | 255.33M | 192.6M | 275.91M | 271.64M | 242.13M |
Total Liabilities | 285.6M | 269.86M | 257.54M | 253.95M | 252.74M | 272.29M | 274.42M | 280.52M | 291.21M | 342.49M | 422.04M | 459.5M | 509.24M | 449.09M | 465.12M | 437.23M | 414.81M |
Total Debt | 54.15M | 47.64M | 48.58M | 104.62M | 98.34M | 104.18M | 57.7M | 58.72M | 82.87M | 99.78M | 100.89M | 134.31M | 135.19M | 136.05M | 123.21M | 124.23M | 125.22M |
Common Stock | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 2K | 1K | 2K | 2K | 2K |
Retained Earnings | -1.67B | -1.68B | -1.66B | -1.64B | -1.63B | -1.61B | -1.61B | -1.6B | -1.58B | -1.55B | -1.55B | -1.49B | -1.52B | -1.46B | -1.39B | -1.33B | -1.25B |
Comprehensive Income | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 9K |
Shareholders Equity | 24.58M | -49.19M | -50.4M | -33.75M | -27.26M | -30.58M | -39.42M | -26.81M | -14.35M | 9.34M | 13.85M | 62.3M | 26.12M | 76.46M | 137.15M | 174.63M | 213.89M |
Total Investments | n/a | n/a | n/a | 1.67M | 1.66M | 1.65M | 1.65M | 1.72M | n/a | 2.7M | n/a | n/a | n/a | 2.04M | n/a | 1.6M | 20M |